Workflow
Globenewswire
icon
Search documents
Nayax Reports Second Quarter 2025 Results
Globenewswire· 2025-08-13 11:30
Revenue of $95.6 million, recurring revenue growth of 32% Gross margin improves to 48.3% Net income of $11.7 million with Adjusted EBITDA of $12.6 million(1) Total transaction value up 34%, Customer base increases 24% Company reaffirms full year 2025 guidance HERZLIYA, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nayax Ltd. (Nasdaq: NYAX, TASE: NYAX), a global commerce payments and loyalty platform designed to help merchants scale their business, today announced its financial results for the second quarter en ...
LIXTE Biotechnology Holdings Updates Corporate Treasury Policy to Include Cryptocurrency
Globenewswire· 2025-08-13 11:30
PASADENA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that its Board of Directors has approved a strategic capital allocation initiative to acquire cryptocurrency as part of its corporate treasury. The Board approved allocation of up to 25 percent of its treasury to cryptocurrencies, including Bitcoin and potentially other digital assets as it deems appropriate. The ...
PolyPid Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Globenewswire· 2025-08-13 11:30
Positive Phase 3 SHIELD II Trial Results - D-PLEX₁₀₀ successfully met its primary efficacy endpoint and demonstrated 58% reduction in SSI NDA submission expected in Q1 2026 Unveiled a Long-Acting GLP-1 Receptor Agonists Delivery Platform Targeting the Obesity and Diabetes Market Successful Warrant Exercise Significantly Strengthened Balance Sheet with Cash Runway into 2026 Conference Call Scheduled for Today at 8:30 AM ET PETACH TIKVA, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (" ...
Creative Realities Reports Fiscal 2025 Second Quarter Results
Globenewswire· 2025-08-13 11:30
Revenue Growth Picks Up as Year Progresses; Company on Track for Record 2025LOUISVILLE, Ky., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Creative Realities, Inc. (“Creative Realities,” “CRI,” or the “Company”) (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, today announced its financial results for the fiscal second quarter ended June 30, 2025. Highlights: Second quarter revenue of $13.0 million versus $13.1 million in the prior-year periodGross profit of $5.0 million for the three ...
Amerigo’s MVC Resumes Fresh Tailings Processing
Globenewswire· 2025-08-13 11:30
El Teniente restarts operations and is sending fresh tailings to MVCHistoric tailings processing remains ongoing Timing of normalized operations at El Teniente to determine impact on MVC guidance VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) provides an operational update on Minera Valle Central (“MVC”), its 100% owned operation located near Rancagua, Chile. On Saturday, August 9, 2025, the El Teniente underground ...
XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements
Globenewswire· 2025-08-13 11:30
Business development: Purchased mezagitamab royalty and milestone rights held by BioInvent International and will secure royalty economic interests in two early-stage partnered assets through XOMA Royalty’s recently announced acquisition of LAVA Therapeutics. Company acquisitions: Announced XOMA Royalty’s acquisitions of Turnstone Biologics, LAVA Therapeutics, and HilleVax; acted as structuring agent and provided financing for XenoTherapeutics’ acquisition of ESSA Pharma; completed the sale of Kinnate pipel ...
BriaCell Selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer
Globenewswire· 2025-08-13 11:30
PHILADELPHIA and VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is pleased to announce its acceptance into Memorial Sloan Kettering Cancer Center’s (MSK’s) Therapeutics Accelerator 2025 Cohort program. This project aims to accelerate the clinical development of Bria-OTS+, BriaCell’s next genera ...
Nexxen Reports Second Quarter 2025 Financial Results
Globenewswire· 2025-08-13 11:30
Generated record Q2 Contribution ex-TAC, programmatic revenue and CTV revenue Increased Adjusted EBITDA Margin to 34% of Contribution ex-TAC from 32% in Q2 2024 Renewed and expanded strategic partnership with VIDAA in Q3 2025 through at least the end of 2029, and increasing investment in VIDAA by $35 million to accelerate their North American CTV and data footprint NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising ...
MasterCraft Boat Holdings, Inc. to Webcast Fiscal Fourth Quarter and Full Year 2025 Earnings Conference Call Wednesday, August 27, 2025
Globenewswire· 2025-08-13 11:30
Live webcast at 8:30 a.m. EDTVONORE, Tenn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) (the “Company”) will host a live webcast of its fiscal fourth quarter and full year 2025 earnings conference call on Wednesday, August 27, 2025, at 8:30 a.m. EDT. Brad Nelson, Chief Executive Officer and Scott Kent, Chief Financial Officer, will discuss the Company’s financial results. The Company will issue a pre-market earnings release prior to the call on August 27, 2025. Participa ...
Base Carbon Reports Second-Quarter 2025 Operating and Financial Results
Globenewswire· 2025-08-13 11:30
TORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (“BCCPC”, together, with affiliates, “Base Carbon”, or the “Company”), is pleased to announce its second-quarter 2025 consolidated financial results and operational highlights. The Company will host an investor town hall in September, with details to follow over the coming weeks. All financial references are denominated in U.S. dol ...